BC Week In Review | Jan 16, 2006
Clinical News

CellCorrect KvA-40 LAb Kit regulatory update

CeMines International, a subsidiary of CeMines Inc. , received CE Mark approval in the EU for CellCorrect LAb , a lung cancer antibody detection kit using Molecular FingerPrinting technology, to aid in the detection and diagnosis of...
BC Week In Review | May 23, 2005
Clinical News

CellCorrect LAb regulatory update

CeMines submitted a 510(k) clearance application for CellCorrect LAb detection kit for lung cancer. The antibody test kit detects cancer cells using the CeMines' Molecular FingerPrinting technology. CeMines Inc. , Golden, Colo.   Product: CellCorrect LAb...
Items per page:
1 - 2 of 2